Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.19B |
| 2 |
Microsoft
MSFT
|
+$1.07B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.06B |
| 4 |
Tesla
TSLA
|
+$1.01B |
| 5 |
Meta Platforms (Facebook)
META
|
+$691M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$689M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$525M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$450M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$305M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.37% |
| 2 | Financials | 9.02% |
| 3 | Communication Services | 7.25% |
| 4 | Consumer Discretionary | 6.95% |
| 5 | Healthcare | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Johnson Outdoors
JOUT
$491M
| $600K | ﹤0.01% |
5,666
+2,166
| +62% | +$247K |
|
3077
Senseonics Holdings Inc
SENS
$263M
| $599K | ﹤0.01% |
8,832
+6,204
| +236% | +$421K |
|
|
BDSI
3078
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $599K | ﹤0.01% |
166,052
+34,456
| +26% | +$130K |
|
3079
CALL
ProShares UltraPro QQQ
TQQQ
$32.1B
| $598K | ﹤0.01% |
19,200
| – | – |
|
3080
Comstock Resources
CRK
$3.89B
| $596K | ﹤0.01% |
57,683
-62,551
| -52% | -$424K |
|
|
FSP
3081
Franklin Street Properties
FSP
$47.2M
| $595K | ﹤0.01% |
128,402
+22,295
| +21% | +$109K |
|
|
JMIA
3082
Jumia Technologies
JMIA
$737M
| $595K | ﹤0.01% |
32,000
+25,000
| +357% | +$529K |
|
3083
Kosmos Energy
KOS
$1.6B
| $590K | ﹤0.01% |
199,450
+65,143
| +49% | +$159K |
|
3084
HCI Group
HCI
$2.23B
| $587K | ﹤0.01% |
5,291
+1,930
| +57% | +$201K |
|
|
HTBK
3085
DELISTED
Heritage Commerce
HTBK
| $587K | ﹤0.01% |
50,462
-12,795
| -20% | -$143K |
|
|
ESPR
3086
DELISTED
Esperion Therapeutics
ESPR
| $585K | ﹤0.01% |
48,606
+14,300
| +42% | +$208K |
|
3087
Civista Bancshares
CIVB
$604M
| $584K | ﹤0.01% |
25,154
+5,397
| +27% | +$124K |
|
3088
MediciNova
MNOV
$65.5M
| $584K | ﹤0.01% |
154,016
+52,856
| +52% | +$201K |
|
|
MRTX
3089
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $584K | ﹤0.01% |
+3,300
| New | +$531K |
|
|
MRTX
3090
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $584K | ﹤0.01% |
+3,300
| New | +$531K |
|
3091
EverQuote
EVER
$892M
| $582K | ﹤0.01% |
31,241
+13,294
| +74% | +$318K |
|
|
SCHW
3092
CALL
Charles Schwab
SCHW
$183B
| $582K | ﹤0.01% |
7,992
| – | – |
|
|
BOCH
3093
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $581K | ﹤0.01% |
38,314
-3,662
| -9% | -$50.9K |
|
3094
Five Point Holdings
FPH
$373M
| $580K | ﹤0.01% |
73,973
+2,855
| +4% | +$23.2K |
|
3095
LegalZoom.com
LZ
$1.35B
| $580K | ﹤0.01% |
21,964
+5,813
| +36% | +$204K |
|
3096
Donegal Group Class A
DGICA
$731M
| $578K | ﹤0.01% |
39,904
+4,184
| +12% | +$62.9K |
|
3097
First Trust Health Care AlphaDEX Fund
FXH
$1.04B
| $578K | ﹤0.01% |
4,852
-9,223
| -66% | -$1.13M |
|
3098
Insteel Industries
IIIN
$593M
| $577K | ﹤0.01% |
15,169
+5,157
| +52% | +$190K |
|
3099
Seaboard Corp
SEB
$4.23B
| $574K | ﹤0.01% |
140
+62
| +79% | +$250K |
|
3100
TriMas Corp
TRS
$1.43B
| $571K | ﹤0.01% |
17,665
+3,567
| +25% | +$110K |
|
Similar funds
Barclays's Q3 2021 Portfolio in Review
As of Q3 2021, Barclays held 5,157 positions worth $222B, up 5% from $212B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $12.8B of net new capital in Q3 2021, opening 259 new positions and adding to 2,650 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Technology Select Sector SPDR ETF, an estimated $689M trimmed.
- Barclays's largest Q3 2021 buy was Invesco Zacks Mid-Cap ETF: 700,000 shares worth $62.9M.
- Barclays added most to Amazon in Q3 2021, an estimated $1.19B increase.
- Barclays's biggest Q3 2021 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $689M.
- Barclays fully exited GE Aerospace in Q3 2021, selling an estimated $248M.
- Barclays's ten largest holdings make up 31% of its $222B portfolio in Q3 2021.
- Barclays opened 259 new positions and closed 365 in Q3 2021.
- Barclays's portfolio value rose 5% quarter-over-quarter to $222B.
Based on Barclays's 13F filing for Q3 2021, filed 9 Nov 2021.